Welcome to our dedicated page for Blue Biofuels SEC filings (Ticker: BIOF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Searching Blue Biofuels’ filings often means digging through dense scientific detail on its patented Cellulose-to-Sugar (CTS) process, plus pages of grant disclosures and dilution clauses. Rather than comb every exhibit, start here.
Stock Titan’s platform delivers AI-powered summaries that turn Blue Biofuels SEC documents into plain English. Need the Blue Biofuels quarterly earnings report 10-Q filing? It arrives within minutes of hitting EDGAR, complete with side-by-side metrics, cash-burn visuals, and segment commentary. Wondering about Blue Biofuels insider trading Form 4 transactions? Real-time alerts flag every executive share movement so you can monitor confidence before the market reacts.
Our coverage spans every form investors ask for:
- 10-K annual report—see R&D spend, licensing strategy, and environmental credit revenue, with a Blue Biofuels annual report 10-K simplified digest.
- 10-Q quarterlies—track pilot-plant progress and funding runway in each Blue Biofuels earnings report filing analysis.
- 8-K—get Blue Biofuels 8-K material events explained when new grants, partnerships, or IP milestones surface.
- DEF 14A proxy—review Blue Biofuels proxy statement executive compensation without parsing legal language.
- Form 4—follow Blue Biofuels Form 4 insider transactions real-time and Blue Biofuels executive stock transactions Form 4.
Whether you’re understanding Blue Biofuels SEC documents with AI for a deep-dive valuation or simply checking dilution risk, Stock Titan streamlines the journey: searchable text, cross-filing links, and expert context in one place. Complex renewable-energy disclosures, finally clear.
Blue Biofuels (BIOF) filed its Q3 2025 10‑Q, reporting no revenue and a net loss of $422,547 for the quarter and $1,587,132 for the nine months ended September 30, 2025. The company recognized $420,030 in DOE grant income in the quarter and $865,000 year‑to‑date, which partially offset operating expenses.
Cash was $95,194 and total liabilities were $4,543,537 as of September 30, 2025. Stockholders’ deficit widened to $3,057,336. Management disclosed “substantial doubt” about the company’s ability to continue as a going concern due to recurring losses, limited liquidity, and the need for additional financing.
During 2025 to date, the company raised cash through equity and debt: $435,000 from private placements of common stock and warrants, $185,000 of related‑party notes, and $6,250 from warrant exercises. Shares outstanding were 315,723,332 as of October 23, 2025; this is a baseline figure, not an amount being offered.
FAQ
What is the current stock price of Blue Biofuels (BIOF)?
What is the market cap of Blue Biofuels (BIOF)?
